OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature
Pablo Coto‐Segura, María Fernández-Prada, Marc Mir‐Bonafé, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 1, pp. 141-143
Open Access | Times Cited: 34
Pablo Coto‐Segura, María Fernández-Prada, Marc Mir‐Bonafé, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 1, pp. 141-143
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees
Ahmed N. Alghamdi, Mohammed I. Alotaibi, Adel S. A. Alqahtani, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 120
Ahmed N. Alghamdi, Mohammed I. Alotaibi, Adel S. A. Alqahtani, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 120
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102898-102898
Open Access | Times Cited: 77
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102898-102898
Open Access | Times Cited: 77
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 22, pp. 5344-5344
Open Access | Times Cited: 87
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 22, pp. 5344-5344
Open Access | Times Cited: 87
Gianluca Avallone, Pietro Quaglino, Francesco Cavallo, et al.
International Journal of Dermatology (2022) Vol. 61, Iss. 10, pp. 1187-1204
Open Access | Times Cited: 54
Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review
Elena Calabria, Federica Canfora, Massimo Mascolo, et al.
Pathology - Research and Practice (2022) Vol. 232, pp. 153834-153834
Open Access | Times Cited: 51
Elena Calabria, Federica Canfora, Massimo Mascolo, et al.
Pathology - Research and Practice (2022) Vol. 232, pp. 153834-153834
Open Access | Times Cited: 51
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID‐19 vaccination: A systematic review and meta‐analysis
Chanudda Washrawirul, Jidapa Triwatcharikorn, Jeerath Phannajit, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 1947-1968
Open Access | Times Cited: 39
Chanudda Washrawirul, Jidapa Triwatcharikorn, Jeerath Phannajit, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 1947-1968
Open Access | Times Cited: 39
Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system
Yixuan Yang, Hua Xie, Shuhan Liu, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Yixuan Yang, Hua Xie, Shuhan Liu, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review
George Kroumpouzos, Maria Eleni Paroikaki, Sara Yumeen, et al.
Microorganisms (2022) Vol. 10, Iss. 3, pp. 624-624
Open Access | Times Cited: 24
George Kroumpouzos, Maria Eleni Paroikaki, Sara Yumeen, et al.
Microorganisms (2022) Vol. 10, Iss. 3, pp. 624-624
Open Access | Times Cited: 24
Meningitis after COVID-19 vaccination, a systematic review of case reports and case series
Amirhomayoun Atefi, Aref Ghanaatpisheh, Amirhosein Ghasemi, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Amirhomayoun Atefi, Aref Ghanaatpisheh, Amirhosein Ghasemi, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study
Dong Seok Lee, Ji Won Kim, Kook Lae Lee, et al.
International Journal of Infectious Diseases (2022) Vol. 118, pp. 173-182
Open Access | Times Cited: 21
Dong Seok Lee, Ji Won Kim, Kook Lae Lee, et al.
International Journal of Infectious Diseases (2022) Vol. 118, pp. 173-182
Open Access | Times Cited: 21
Cutaneous reactions after COVID ‐19 vaccination in Turkey: A multicenter study
Filiz Cebeci, Sevil Savaş Erdoğan, Nurhan Döner Aktaş, et al.
Journal of Cosmetic Dermatology (2022) Vol. 21, Iss. 9, pp. 3692-3703
Open Access | Times Cited: 20
Filiz Cebeci, Sevil Savaş Erdoğan, Nurhan Döner Aktaş, et al.
Journal of Cosmetic Dermatology (2022) Vol. 21, Iss. 9, pp. 3692-3703
Open Access | Times Cited: 20
Linear Immunoglobulin a Bullous Dermatosis in Children
Francesca Mori, Francesca Saretta, Lucia Liotti, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 17
Francesca Mori, Francesca Saretta, Lucia Liotti, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 17
Linear IgA bullous dermatosis following Oxford AstraZeneca COVID‐19 vaccine
F. Hali, A. Kerouach, Hind Alatawna, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 3, pp. 611-613
Open Access | Times Cited: 21
F. Hali, A. Kerouach, Hind Alatawna, et al.
Clinical and Experimental Dermatology (2021) Vol. 47, Iss. 3, pp. 611-613
Open Access | Times Cited: 21
Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine
Joseph Han, Gerardo J. Russo, Scott Stratman, et al.
JAAD Case Reports (2022) Vol. 24, pp. 101-104
Open Access | Times Cited: 14
Joseph Han, Gerardo J. Russo, Scott Stratman, et al.
JAAD Case Reports (2022) Vol. 24, pp. 101-104
Open Access | Times Cited: 14
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine
Anna Pira, Jo Linda Sinagra, Francesco Moro, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Anna Pira, Jo Linda Sinagra, Francesco Moro, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review
Po‐Chien Wu, I‐Hsin Huang, Ching-Ya Wang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 465-465
Open Access | Times Cited: 2
Po‐Chien Wu, I‐Hsin Huang, Ching-Ya Wang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 465-465
Open Access | Times Cited: 2
Significance of digestive symptoms after COVID-19 vaccination: A retrospective single-center study
Dong Seok Lee, Ji Won Kim, Kook Lae Lee, et al.
The American Journal of Emergency Medicine (2022) Vol. 58, pp. 154-158
Open Access | Times Cited: 11
Dong Seok Lee, Ji Won Kim, Kook Lae Lee, et al.
The American Journal of Emergency Medicine (2022) Vol. 58, pp. 154-158
Open Access | Times Cited: 11
Eosinophil‐rich linear IgA bullous dermatosis induced by mRNA COVID ‐19 booster vaccine
William J. Nahm, Michelle C. Juarez, Julie H. Wu, et al.
Journal of Cutaneous Pathology (2022) Vol. 50, Iss. 1, pp. 24-28
Open Access | Times Cited: 9
William J. Nahm, Michelle C. Juarez, Julie H. Wu, et al.
Journal of Cutaneous Pathology (2022) Vol. 50, Iss. 1, pp. 24-28
Open Access | Times Cited: 9
Association between COVID-19 vaccination and bullous pemphigoid – a case series and literature review
Vincent Wan, Dilys Chen, Carolyn J Shiau, et al.
SAGE Open Medical Case Reports (2022) Vol. 10
Open Access | Times Cited: 7
Vincent Wan, Dilys Chen, Carolyn J Shiau, et al.
SAGE Open Medical Case Reports (2022) Vol. 10
Open Access | Times Cited: 7
Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review
Farhan Mahmood, Janelle Cyr, Amy Li, et al.
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 3, pp. 260-270
Open Access | Times Cited: 3
Farhan Mahmood, Janelle Cyr, Amy Li, et al.
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 3, pp. 260-270
Open Access | Times Cited: 3
New-Onset Pemphigoid Gestationis Following COVID-19 Vaccination
Danielle E. Mustin, Thomas B Huffaker, Ron J. Feldman
Cutis (2023) Vol. 111, Iss. 5
Open Access | Times Cited: 3
Danielle E. Mustin, Thomas B Huffaker, Ron J. Feldman
Cutis (2023) Vol. 111, Iss. 5
Open Access | Times Cited: 3
Linear IgA bullous dermatosis after COVID ‐19 vaccination
Henry Zou, Steven Daveluy
International Journal of Dermatology (2022) Vol. 62, Iss. 2
Open Access | Times Cited: 4
Henry Zou, Steven Daveluy
International Journal of Dermatology (2022) Vol. 62, Iss. 2
Open Access | Times Cited: 4
Dermatosis IgA lineal tras la vacuna de COVID-19
Marta Cebolla‐Verdugo, María Zulaika-Lloret, Mar Rodriguez-Troncoso, et al.
Piel (2024) Vol. 39, Iss. 7, pp. 463-465
Closed Access
Marta Cebolla‐Verdugo, María Zulaika-Lloret, Mar Rodriguez-Troncoso, et al.
Piel (2024) Vol. 39, Iss. 7, pp. 463-465
Closed Access
Side effects of COVID-19 vaccines in the middle eastern population
Ghida M. Murished, Iman Dandachi, Waleed Aljabr
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Ghida M. Murished, Iman Dandachi, Waleed Aljabr
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist
Sonia Himed, Ashley Gray, Zaynah Awethe, et al.
Current Dermatology Reports (2022) Vol. 11, Iss. 4, pp. 252-262
Open Access | Times Cited: 2
Sonia Himed, Ashley Gray, Zaynah Awethe, et al.
Current Dermatology Reports (2022) Vol. 11, Iss. 4, pp. 252-262
Open Access | Times Cited: 2
